Sandra Milligan
CIK 1859810 · Interim CEO · last filed 2026-06-05
Sandra Milligan is an Interim CEO who has filed 26 SEC Form 4 insider transactions across 4 companies since 2021. The most recent filing, for GOSS, was dated Jun 5, 2026. Across all open-market trades the lifetime net is +$75.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $428.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$428.1K
4
26
$75.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GOSS | Director | 90,050 | $0.16 | $14.6K | $75.2K | 8 | 2026-06-05 |
| SYRE | Director | — | $80.79 | — | $0 | 3 | 2026-05-29 |
| Aspira Women's Health Inc. (AWH) Delisted | Interim CEO | 13,644 | $0.08 | $1.1K | $0 | 5 | 2025-01-29 |
| OGN | Head of Research & Development | 30,767 | $13.44 | $413.5K | $0 | 10 | 2023-05-08 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2026-05-29 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2025-08-20 | GOSS | Buy (P) | +26,050 | $50.0K | EDGAR |
| 2025-06-26 | GOSS | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2025-01-29 | Aspira Women's Health Inc. (AWH) Delisted | Mixed | +13,644 | -$4.4K | EDGAR |
| 2025-01-08 | Aspira Women's Health Inc. (AWH) Delisted | Exer (M) | +20,000 | $0 | EDGAR |
| 2024-11-13 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-10-28 | Aspira Women's Health Inc. (AWH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-06 | GOSS | Grant (A) | — | $0 | EDGAR |